Objective: To assess the interaction between versional and vergence eye movements in normal and strabismic monkeys. Methods: Horizontal optokinetic nystagmus (OKN) and vergence were measured using the magnetic scleral search coil technique in a normal adult monkey and a strabismic monkey who had naturally occurring early-onset esotropia. Mean eye velocity and vergence angles were calculated during the slow phases of OKN. Results: The strabismic monkey had a nasotemporal asymmetry of OKN favoring nasally directed motion in each eye. During monocular optokinetic stimulation, mean eye velocities were substantially greater for the adducting as compared to the abducting eye. The velocity of the abducting eye was between 55 and 80% of the velocity of the adducting eye (p < 0.01). As a consequence of the disjunctive movements, the eyes converged an average of 4 ± 2.8° during OKN. Saccadic analysis documented normal lateral rectus function in each eye. Neither an OKN asymmetry nor disjunctive OKN was observed in the normal monkey. Conclusion: Disjunctive OKN in the esotropic monkey suggests that the cerebral maldevelopment responsible for nasally biased OKN also contributes to nasal biases in vergence pathways.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.